1. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014 Oct 1;6(10):a016295. doi: 10.1101/cshperspect.a016295. PMID: 25190079.
2. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011 Sep;23(5):471-8. doi: 10.1097/BOR.0b013e328349c2b0. PMID: 21788902.
3. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 2009 Jan;41(1):40-59. PMID: 18662800.
4. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013 Jan;15(1):195-218. doi: 10.1208/s12248-012-9432-8. PMID: 23143785.
5. Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci. 2011 May;73(3):255-61. PMID: 22457547.
6. Institut Pasteur — Équipe Immunologie des infections virales et maladies auto-immunes (2019). Capacité régénérative du cartilage humain et mécanismes bloquants inflammatoires. Paris, France.
7. INSERM — Unité 1132 (BIOSCAR). Physiopathologie et traitement des maladies ostéoarticulaires. Hôpital Lariboisière, Paris.